Referred to us by a banker, Enlivex initially engaged with us to refine their brand and messaging to showcase their clinical advancements and sought to more clearly communicate its science to investors and partners. 

We worked closely with the team to develop a new narrative, simplifying complex immunology into a clear and differentiated story. We created scientific and mechanism-of-action illustrations, revamped the investor deck, and translated the narrative into a new website built from the ground up to ensure consistency across all investor materials. 

As Enlivex evolved, we supported a second strategic shift as the company introduced a first-of-its-kind treasury model anchored in the RAIN protocol, integrating this new approach to reflect both the company’s clinical progress and financial strategy. 

The result is a modern digital presence that has evolved alongside the company through multiple stages of growth.